Business

Microbot Medical to Unveil World’s First Fully Disposable Robotic System for Endovascular Procedures

Live Demonstration Planned for Monday, January 13, 2020, in San FranciscoBreakthrough technology features compact design, remote operation capabilities and an

articleMicrobot Medical Inc.December 23, 20193/company/microbot-medical-inc/news/microbot-medical-to-unveil-worlds-first-fully-disposable-robotic-system-for-endovascular-procedures
Microbot Medical to Unveil World’s First Fully Disposable Robotic System for Endovascular Procedures

About this update from Microbot Medical Inc.

[{"type":"text","content":"Live Demonstration Planned for Monday, January 13, 2020, in San FranciscoBreakthrough technology features compact design, remote operation capabilities and an integrated “One & Done” tool to democratize endovascular procedures HINGHAM, Mass., Dec. 23, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT) today announced the revealing of LIBERTYTM, the world’s first fully disposable robotic system for use in neurovascular, cardiovascular and peripheral vascular procedures. The LIBERTY robotic system features a unique compact design with the capability to be operated remotely, reduce radiation exposure and physical strain to the physician, as well as the potential to eliminate the use of multiple consumables through its “One & Done” capabilities. Microbot is set to publicly display and demonstrate LIBERTY to investors, journalists and healthcare industry leaders on Monday, January 13, 2020, in San Francisco.\n A Media Snippet accompanying this announcement is available by clicking on the image or link below: Microbot Medical Media Snippet: Microbot Medical “LIBERTY is set to revolutionize the way surgical robotics are being used in endovascular procedures, by eliminating the need for capital equipment, reducing radiation exposure and aiming to streamline the use of disposables during these complex procedures,” commented Harel Gadot, Chief Executive Officer, President, and Chairman. “In addition, with LIBERTY’s remote operation as well as its “One & Done” capabilities, we believe it has the potential to be the first system to democratize endovascular interventional procedures.” LIBERTY is set to revolutionize the way surgical robotics are being used in endovascular procedures, by eliminating the need for capital equipment, reducing radiation exposure and aiming to streamline the use of disposables. -Harel Gadot, CEO of Microbot. Click to tweet link: https://ctt.ac/9DV2b Dr. Eyal Morag, an ABR certified Interventional Radiologist and Chairman of Radiology and Nuclear Medicine at Assuta Ashdod Medical Center in Israel, will be performing the live demonstrations highlighting the unique capabilities of LIBERTY. “I believe LIBERTY will be welcomed by the interventional community due to its clinical and technical benefits in various subspecialties, such as neurovascular, cardiovascular and peripheral vascular interventions,” comm...

More updates from Microbot Medical Inc.